Bruce D Gelb, MD
img_Bruce D Gelb
DIRECTOR MINDICH CHILD HEALTH AND DEVELOPMENT INSTITUTE
PROFESSOR | Pediatrics, Cardiology
PROFESSOR | Genetics and Genomic Sciences
Are you a patient?
Specialties
Pediatrics, Pediatric Cardiology
Research Topics
Cardiovascular, Gene Discovery, Human Genetics and Genetic Disorders, Pediatrics, Signal Transduction, Stem Cells, Transgenic Mice
Multi-Disciplinary Training Area
Development Regeneration and Stem Cells [DRS], Genetics and Genomic Sciences [GGS]

Specific Clinical/Research Interests:
Genetics of congenital heart defects; Noonan syndrome and related disorders; Gain-of-function RAS signaling

Genetic Counselor: Meghan Mac Neal

Postdoctoral Fellows: Se-Yeon Lee, Kathryn Manheimer

Predoctoral Students: Felix Richter, Nelson Rodriguez

Research Personnel: Jian Zhang, Simon Ng, Jared Gatto, Tara Keshavarz, Yahaira Mendez


Summary of Research Studies:


The Gelb research group is focused on disease gene discovery using genomic techniques and characterization of the biological roles of such genes in disease pathogenesis. The focus of the laboratory currently is on those traits that are associated with heart malformations. In the past, we have identified disease genes for Char and Noonan syndromes. The former is TFAP2B, which encodes a transcription factor of the AP-2 family, and the latter include PTPN11, KRAS, SOS1, SOS2, RAF1 and SHOC2. We are studying the roles of these disease genes in normal developmental and homeostatic processes as well as in disease pathogenesis. We are actively studying additional human genetic traits, both simple and complex, to identify additional disease genes with a particular focus on traits with cardiovascular abnormalities. This is being done with next generation sequencing approaches, both whole exome and genome sequencing. Ongoing biologic studies focus on disease modeling using induced pluripotent stem cells, including creating mutations or correcting them with CRISPR technology. We are also studying disease genes and performing drug discovery in Drosophila melanogaster.

MD, University of Rochester School of Medicine/Dentistry

Residency, Pediatrics, Columbia Presbyterian Medical Center

Fellowship, Pediatric Cardiology, Texas Children's Hospital

Certifications

American Board of Pediatrics

2016

Best Doctors

New York Magazine

2015

Best Doctors

New York Magazine

2010

Best Doctors

New York Magazine

Publications

Selected Publications

Rapid Genome Sequencing Compared with a Gene Panel in Critically Ill Infants with a Suspected Genetic Disorder: An Economic Evaluation. Tara A. Lavelle, Jill L. Maron, Stephen F. Kingsmore, Ching Hsuan Lin, Yingying Zhu, Benjamin Sweigart, Dallas Reed, Bruce D. Gelb, Jerry Vockley, Jonathan M. Davis. Journal of Pediatrics

An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser. Isabelle B. Cooperstein, Shruti Marwaha, Alistair Ward, Shilpa N. Kobren, Jennefer N. Carter, Ziyuan Guo, Zackary Dov Berger, Yuka Manabe, Yong Hui Jiang, Yigit Karasozen, Yan Huang, Winston Timp, Winston Halstead, William J. Craigen, William E. Byrd, William A. Gahl, Willa Thorson, Wendy Raskind, Wendy Introne, Vishnu Cuddapah, Virginia Sybert, Vasilis Vasiliou, Vandana Shashi, Valerie V. Maduro, Vaidehi Jobanputra, Tiphanie P. Vogel, Timothy Schedl, Thomas J. Nicholas, Thomas Cassini, Terra R. Coakley, Teodoro Jerves Serrano, Teneasha Washington, Taylor Maurer, Taylor Beagle, Tarun K.K. Mamidi, Tanner D. Jensen, Tammi Skelton, Tahseen Mozaffar, Suzanne Sandmeyer, Susan Shin, Susan Korrick, Surendra Dasari, Suha Bachir, Steven Boyden, Saskia Shuman, Manisha Balwani, Mafalda Barbosa, Joanna Jen, Charlotte Cunningham-Rundles, Bruce Gelb. Genome Medicine

Enrichment of tandem repeat element variants near CHD genes identified by short- and long-read genome sequencing. Abhilash Suresh, Sarah U. Morton, Daniel Quiat, Steven R. DePalma, Joshua M. Gorham, Martina Brueckner, Martin Tristani-Firouzi, Bruce D. Gelb, Jonathan G. Seidman, Christine E. Seidman. BMC Medical Genomics

View All Publications

Bruce Gelb, MD
Cardiovascular Genetics Program

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Gelb during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

  • American Society of Human Genetics

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Baylor Genomics
  • Pessin Katz Law, PA
  • Garson Jakub & Morris, LLP
  • Wilson, elser, Moskowitz, Edelman & Dicker, LLP
  • Biomarin Pharmaceutical
  • WCG Clinical
  • Think Bioscience
  • Rendigs, Fry, Kiely & Dennis, LLP

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Think Bioscience

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.